Atheroembolic kidney disease: The under‐recognized silent killer

While kidney biopsy demonstrating cholesterol crystal emboli is the method of definitive diagnosis; the triad of acute to subacute renal failure with skin findings in the setting of recent precipitating event should raise clinical suspicion for atheroembolic kidney disease.

Detalles Bibliográficos
Autores principales: Ștefan, Gabriel, Zugravu, Adrian, Stancu, Simona, Gherghiceanu, Mihaela, Terinte‐Balcan, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Images
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981600/
https://www.ncbi.nlm.nih.gov/pubmed/33768956
http://dx.doi.org/10.1002/ccr3.3874
_version_ 1783667544446468096
author Ștefan, Gabriel
Zugravu, Adrian
Stancu, Simona
Gherghiceanu, Mihaela
Terinte‐Balcan, George
author_facet Ștefan, Gabriel
Zugravu, Adrian
Stancu, Simona
Gherghiceanu, Mihaela
Terinte‐Balcan, George
author_sort Ștefan, Gabriel
collection PubMed
description While kidney biopsy demonstrating cholesterol crystal emboli is the method of definitive diagnosis; the triad of acute to subacute renal failure with skin findings in the setting of recent precipitating event should raise clinical suspicion for atheroembolic kidney disease.
format Online
Article
Text
id pubmed-7981600
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-79816002021-03-24 Atheroembolic kidney disease: The under‐recognized silent killer Ștefan, Gabriel Zugravu, Adrian Stancu, Simona Gherghiceanu, Mihaela Terinte‐Balcan, George Clin Case Rep Clinical Images While kidney biopsy demonstrating cholesterol crystal emboli is the method of definitive diagnosis; the triad of acute to subacute renal failure with skin findings in the setting of recent precipitating event should raise clinical suspicion for atheroembolic kidney disease. John Wiley and Sons Inc. 2021-01-28 /pmc/articles/PMC7981600/ /pubmed/33768956 http://dx.doi.org/10.1002/ccr3.3874 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Images
Ștefan, Gabriel
Zugravu, Adrian
Stancu, Simona
Gherghiceanu, Mihaela
Terinte‐Balcan, George
Atheroembolic kidney disease: The under‐recognized silent killer
title Atheroembolic kidney disease: The under‐recognized silent killer
title_full Atheroembolic kidney disease: The under‐recognized silent killer
title_fullStr Atheroembolic kidney disease: The under‐recognized silent killer
title_full_unstemmed Atheroembolic kidney disease: The under‐recognized silent killer
title_short Atheroembolic kidney disease: The under‐recognized silent killer
title_sort atheroembolic kidney disease: the under‐recognized silent killer
topic Clinical Images
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981600/
https://www.ncbi.nlm.nih.gov/pubmed/33768956
http://dx.doi.org/10.1002/ccr3.3874
work_keys_str_mv AT stefangabriel atheroembolickidneydiseasetheunderrecognizedsilentkiller
AT zugravuadrian atheroembolickidneydiseasetheunderrecognizedsilentkiller
AT stancusimona atheroembolickidneydiseasetheunderrecognizedsilentkiller
AT gherghiceanumihaela atheroembolickidneydiseasetheunderrecognizedsilentkiller
AT terintebalcangeorge atheroembolickidneydiseasetheunderrecognizedsilentkiller

Ejemplares similares